SS
OLMA icon

SBI Securities’s Olema Pharmaceuticals OLMA Stock Holding History

SBI Securities’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$910 Hold
61
– – ﹤0.01% 2689
2025
Q4 		$1.52K Buy
61
+10
+20% +$178 ﹤0.01% 2494
2025
Q3 		$499 Hold
51
– – ﹤0.01% 2968
2025
Q2 		$217 Buy
51
+16
+46% +$71 ﹤0.01% 3281
2025
Q1 		$132 Hold
35
– – ﹤0.01% 3361
2024
Q4 		$204 Buy
+35
New +$350 ﹤0.01% 3233

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

SBI Securities's OLMA Position: Q1 2026 in Review

SBI Securities held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 61 shares worth $910. The position accounts for ﹤0.01% of the portfolio, ranked #2689.

SBI Securities first reported a position in OLMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.52K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • SBI Securities held 61 shares of Olema Pharmaceuticals worth $910 as of Q1 2026.
  • SBI Securities left its Olema Pharmaceuticals share count unchanged in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2689 holding.
  • SBI Securities first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Olema Pharmaceuticals position peaked at $1.52K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.